India to United States: Sunitinib Export Trade Route
India has recorded 68 verified shipments of Sunitinib exported to United States, representing a combined trade value of $21.8M USD. This corridor is served by 8 active Indian exporters, with an average shipment value of $320.0K USD. The leading Indian exporter is SUN PHARMACEUTICAL INDUSTRIES LIMITED, which accounts for 43% of total export value with 45 shipments worth $9.5M USD. On the buying side, XX RXXDYSXXABOXXTORXXS IXX is the largest importer in United States with $5.0M USD in purchases. The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, DR REDDY S LABORATORIES LIMITED, DR REDDYS LABORATORIES LIMITED — together control 89% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Sunitinib corridor is one of India's established pharmaceutical export routes, with 68 shipments documented worth a combined $21.8M USD. The route is dominated by SUN PHARMACEUTICAL INDUSTRIES LIMITED, which alone accounts for roughly 43% of all export value, reflecting the consolidated nature of India's sunitinib manufacturing sector.
Across 8 active suppliers, the average shipment value stands at $320.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (68%) and air (17%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during July–September, with an average transit time of 27 days port-to-port. The route has recorded an annual growth rate of 19.1%, placing it at rank #2 among India's top sunitinib export destinations globally.
On the import side, key buyers of Indian sunitinib in United States include XX RXXDYSXXABOXXTORXXS IXX, DR REDDYS LABORATORIES INC, SUN PHARMACEUTICAL INDUSTRIES,INC. and 9 others. XX RXXDYSXXABOXXTORXXS IXX is the single largest importer with 1 shipments valued at $5.0M USD.
Route Characteristics
- Average transit27 days
- Peak seasonQ3
- Primary modeMulti-modal
- Top portSAHAR AIR
Market Position
- Global rank#2
- Annual growth+19.1%
- Demand growth+16.4%
- Regulatory ease68/100
Top 10 Indian Sunitinib Exporters to United States
Showing top 10 of 8 Indian suppliers exporting Sunitinib to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SUN PHARMACEUTICAL INDUSTRIES LIMITED Avg $210.1K per shipment | 45 | $9.5M | 43.4% |
| 2 | DR REDDY S LABORATORIES LIMITED Avg $5.0M per shipment | 1 | $5.0M | 22.9% |
| 3 | DR REDDYS LABORATORIES LIMITED Avg $5.0M per shipment | 1 | $5.0M | 22.8% |
| 4 | SUN PHARMACEUTICAL INDUSTRIES LTD Avg $236.3K per shipment | 9 | $2.1M | 9.8% |
| 5 | MSN LABORATORIES PRIVATE LIMITED Avg $36.8K per shipment | 4 | $147.2K | 0.7% |
| 6 | TEYRO LABS PRIVATE LIMITED Avg $17.9K per shipment | 5 | $89.5K | 0.4% |
| 7 | GLOBYZ BIOPHARMA PRIVATE LIMITED Avg $325 per shipment | 2 | $649 | 0.0% |
| 8 | ATLAS ENTERPRISES Avg $260 per shipment | 1 | $260 | 0.0% |
This table shows the top 10 of 8 Indian companies exporting sunitinib to United States, ranked by total trade value. The listed exporters are: SUN PHARMACEUTICAL INDUSTRIES LIMITED, DR REDDY S LABORATORIES LIMITED, DR REDDYS LABORATORIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LTD, MSN LABORATORIES PRIVATE LIMITED, TEYRO LABS PRIVATE LIMITED, GLOBYZ BIOPHARMA PRIVATE LIMITED, ATLAS ENTERPRISES. SUN PHARMACEUTICAL INDUSTRIES LIMITED is the dominant supplier with 45 shipments worth $9.5M USD, giving it a 43% market share. The top 3 suppliers together account for 89% of the total trade value on this route.
Top 10 Sunitinib Importers in United States
Showing top 10 of 12 known buyers in United States receiving Sunitinib shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian sunitinib in United States include XX RXXDYSXXABOXXTORXXS IXX, DR REDDYS LABORATORIES INC, SUN PHARMACEUTICAL INDUSTRIES,INC., SUN PHARMACEUTICAL INDUSTRIES INC, NORTHSTAR DISTRIBUTION CENTER 8912, among 12 total buyers. The largest importer is XX RXXDYSXXABOXXTORXXS IXX, accounting for $5.0M USD across 1 shipments — representing 23% of all sunitinib imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | XX RXXDYSXXABOXXTORXXS IXX | 1 | $5.0M | 22.9% |
| 2 | DR REDDYS LABORATORIES INC | 1 | $5.0M | 22.8% |
| 3 | SUN PHARMACEUTICAL INDUSTRIES,INC. | 20 | $4.9M | 22.3% |
| 4 | SUN PHARMACEUTICAL INDUSTRIES INC | 13 | $2.9M | 13.3% |
| 5 | NORTHSTAR DISTRIBUTION CENTER 8912 | 14 | $1.8M | 8.2% |
| 6 | Northstar Distribution Center 8912 | 2 | $1.2M | 5.4% |
| 7 | MS | 2 | $478.1K | 2.2% |
| 8 | SUN PHARMACEUTICAL INDUSTRIES,INC | 2 | $226.9K | 1.0% |
| 9 | TO, | 1 | $166.7K | 0.8% |
| 10 | TO THE ORDER OF | 6 | $147.8K | 0.7% |
Showing top 10 of 12 Sunitinib importers in United States on this route.
Top 10 Sunitinib Formulations Imported by United States
Showing top 10 of 48 product formulations shipped on the India to United States Sunitinib route, ranked by trade value
United States imports a wide range of sunitinib formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — SUNITINIBMALATE CAPS37.5MG28'SBOTUS(NEW) — accounts for $5.0M USD across 1 shipments. There are 48 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SUNITINIBMALATE CAPS37.5MG28'SBOTUS(NEW) | 1 | $5.0M | 22.9% |
| 2 | SUNITINIBMALATE CAPS37.5MG28'SBOTUSNEW | 1 | $5.0M | 22.8% |
| 3 | SUNITINIB MALATE CAPS 25MG 28CRC USA PACK : 28 CAPSULE (BATCH NO AS PER INVOICE) | 3 | $1.4M | 6.5% |
| 4 | SUNITINIB MALATE CAPS 25MG 28BTL NS US P | 3 | $1.3M | 5.9% |
| 5 | SUNITINIB MALATE CAPS 50MG 28CRC USA PAC | 4 | $1.2M | 5.6% |
| 6 | SUNITINIB MALATE CAPS 50MG 28CRC USA PACK : 28 CAPSULE (BATCH NO AS PER INVOICE) | 2 | $1.1M | 5.2% |
| 7 | SUNITINIB MALATE CAPS 37.5MG 28CRC USA P | 5 | $920.3K | 4.2% |
| 8 | SUNITINIB MALATE CAPS 37.5MG 28CRC USA PACK : 28 CAPSULE (BATCH NO AS PER INVOICE) | 3 | $854.8K | 3.9% |
| 9 | SUNITINIB MALATE CAPS 25MG 28CRC USA PAC | 4 | $684.5K | 3.1% |
| 10 | SUNITINIB MALATE CAP 37.5MG 28BTL NS US, | 1 | $391.1K | 1.8% |
Showing top 10 of 48 Sunitinib formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 68% sea for bulk, 17% air for urgent orders.
Top Ports of Origin
SAHAR AIR handles the highest volume with 19 shipments. Transit time averages 27 days by sea.
Market Dynamics
India's sunitinib exports to United States are driven primarily by a handful of large-scale manufacturers. SUN PHARMACEUTICAL INDUSTRIES LIMITED with 45 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 8 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, DR REDDY S LABORATORIES LIMITED, DR REDDYS LABORATORIES LIMITED — together account for 89% of total trade value on this route. The average shipment value of $320.0K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as sunitinibmalate caps37.5mg28'sbotusnew and sunitinib malate caps 25mg 28crc usa pack : 28 capsule (batch no as per invoice), suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, XX RXXDYSXXABOXXTORXXS IXX is the largest importer with 1 shipments worth $5.0M USD — representing 23% of all sunitinib imports from India on this route. A total of 12 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $21.8M
- Avg. Shipment
- $320.0K
- Suppliers
- 8
- Buyers
- 12
- Transit (Sea)
- ~27 days
- Annual Growth
- +19.1%
Reverse Direction
United States → India — Sunitinib (Import)Other Sunitinib Routes
Unlock the Full India to United States Sunitinib Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 68 shipments on this route.
Frequently Asked Questions — India to United States Sunitinib Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Sunitinib to United States?
The leading Indian exporters of Sunitinib to United States are SUN PHARMACEUTICAL INDUSTRIES LIMITED, DR REDDY S LABORATORIES LIMITED, DR REDDYS LABORATORIES LIMITED. SUN PHARMACEUTICAL INDUSTRIES LIMITED holds the largest market share at approximately 43% of total trade value on this route.
Q What is the total value of Sunitinib exports from India to United States?
India exports Sunitinib to United States worth approximately $21.8M USD across 68 recorded shipments. The average value per shipment is $320.0K USD.
Q Which ports does India use to ship Sunitinib to United States?
The most active port of origin is SAHAR AIR with 19 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 68% of shipments going by sea and 17% by air.
Q How long does shipping take from India to United States for Sunitinib?
The average transit time for Sunitinib shipments from India to United States is approximately 27 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during July–September.
Q Is the India to United States Sunitinib trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 19.1% with demand growth tracking at 16.4%. The route is ranked #2 among India's top Sunitinib export destinations globally.
Q How many suppliers are active on the India to United States Sunitinib route?
There are currently 8 active Indian suppliers exporting Sunitinib to United States. The market is moderately concentrated with SUN PHARMACEUTICAL INDUSTRIES LIMITED accounting for 43% of total shipment value.
Q Who are the main importers of Sunitinib from India in United States?
The leading importers of Indian Sunitinib in United States include XX RXXDYSXXABOXXTORXXS IXX, DR REDDYS LABORATORIES INC, SUN PHARMACEUTICAL INDUSTRIES,INC., SUN PHARMACEUTICAL INDUSTRIES INC, NORTHSTAR DISTRIBUTION CENTER 8912. XX RXXDYSXXABOXXTORXXS IXX is the largest buyer with 1 shipments worth $5.0M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Sunitinib.
- 2.Supplier/Buyer Matching: 8 Indian exporters and 12 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 68 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
68 Verified Shipments
8 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists